US EditionPublished • loading... • Updated
Hundreds of pregnancy drug victims call for public inquiry into 'silent scandal'
More than 300 UK women exposed to DES seek government accountability for decades of harm including infertility and rare cancers linked to the pregnancy drug.
- DES Justice UK — representing more than 300 people — is demanding a public inquiry, redress scheme, and screening programme from the United Kingdom Government.
- Diethylstilbestrol was a synthetic oestrogen prescribed to around 300,000 women from the 1940s to the late 1970s; researchers linked it to cancer, but European prescribing continued until 1978.
- Affected family members recount infertility, ectopic pregnancies, six rounds of IVF before having Issy Taylor, 25, and cancers including a niece, 46, with breast cancer linked to DES.
- The MHRA has apologised and explained that 1973 CSM correspondence did not contraindicate DES; the Secretary of State has asked NHS England to ensure GPs follow up with local cancer alliances.
- Compared with the UK, other countries like the United States and the Netherlands have compensation schemes and screening programmes, while DES Justice UK formed after an ITV News year-long investigation highlights liability challenges from drug manufacturers.
Insights by Ground AI
9 Articles
9 Articles
Hundreds of victims of ‘silent scandal’ pregnancy drug call for public inquiry
Diethylstilbestrol (DES) was prescribed to pregnant women from 1940 to the 1970s to prevent miscarriage, premature labour and pregnancy complications. Hundreds of victims of a “silent scandal” involving a pregnancy drug linked to cancer are calling on the Government to launch a public inquiry. More than 300 people have formed the group DES Justice UK (DJUK) for those affected by diethylstilbestrol, a synthetic form of the female hormone oestroge…
Coverage Details
Total News Sources9
Leaning Left3Leaning Right0Center5Last UpdatedBias Distribution62% Center
Bias Distribution
- 62% of the sources are Center
62% Center
L 38%
C 62%
Factuality
To view factuality data please Upgrade to Premium
